Controlling gene expression to halt cancer growth
Tuesday, October 25, 2011 - 05:30
in Health & Medicine
(Medical Xpress) -- NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.